title: [Antihyperglycemic Treatment Guidelines for diabetes mellitus type 2].
abstract: Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets in regard of optimal therapeutic efficacy and high therapeutic safety is of great importance. In this guideline we present the best and most current evidence-based clinical practice data for healthcare professionals.
authors.affiliation: Interne Abteilung mit Endokrinologie und Stoffwechsel, Gastroenterologie, Rheumatologie und Intensivmedizin, Krankenhaus der Barmherzigen Brüder Linz, Linz, Österreich. martin.clodi@meduniwien.ac.at
authors.forename: Martin
authors.initials: M
authors.lastname: Clodi
authors.forename: H Eidemarie
authors.initials: HE
authors.lastname: Abrahamian
authors.forename: Heinz
authors.initials: H
authors.lastname: Drexel
authors.forename: Peter
authors.initials: P
authors.lastname: Fasching
authors.forename: Friedrich
authors.initials: F
authors.lastname: Hoppichler
authors.forename: Alexandra
authors.initials: A
authors.lastname: Kautzky-Willer
authors.forename: Monika
authors.initials: M
authors.lastname: Lechleitner
authors.forename: Bernhard
authors.initials: B
authors.lastname: Ludvik
authors.forename: Rudolf
authors.initials: R
authors.lastname: Prager
authors.forename: Michael
authors.initials: M
authors.lastname: Roden
authors.forename: Christoph
authors.initials: C
authors.lastname: Saely
authors.forename: Guntram
authors.initials: G
authors.lastname: Schernthaner
authors.forename: Edith
authors.initials: E
authors.lastname: Schober
authors.forename: Hermann
authors.initials: H
authors.lastname: Toplak
authors.forename: Thomas
authors.initials: T
authors.lastname: Wascher
authors.forename: Raimund
authors.initials: R
authors.lastname: Weitgasser
mesh_terms: D001317:Austria; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D038622:Internationality; D017410:Practice Guidelines as Topic
chemical_list: D007004:Hypoglycemic Agents